Stanford Study Reveals Human Brain Originates from Two Distinct Neural Systems

Key points

• Stanford Medicine researchers, led by Kyle Loh, identified two distinct progenitor cells during embryonic development: one expressing the Otx2 gene for the forebrain/midbrain and another expressing Gbx2 for the hindbrain.
• The forebrain and hindbrain have fundamentally different chromatin configurations, locking them into separate developmental fates that never overlap, contrary to the previous 'single master cell' theory.
• Using this knowledge, the team successfully coaxed human pluripotent stem cells into functional hindbrain motor neurons, a feat previously considered impossible.
• This breakthrough enables lab-based study of hindbrain diseases, including SMA (a leading cause of death in infants) and ALS, which affect breathing and swallowing functions controlled by the hindbrain.
• Evolutionary analysis shows this dual-system pattern exists in chickens, zebrafish, and acorn worms, suggesting the two nervous systems were 'squished together' over 550 million years of evolution.

Background

This discovery follows recent Stanford research involving the transplantation of human brain tissue into mice to study neurodevelopment and diseases like cerebral palsy and frontotemporal dementia. While those studies focused on integrating human cortical neurons into animal models, the current research addresses the fundamental embryonic origins of the brain's structure, providing a new foundation for understanding how different brain regions develop and fail in disease states.

How outlets are covering it

Coverage of the study is predominantly center-leaning, with 49% of the 157 tracked sources categorized as center. Most outlets, including Stanford Medicine, Nature, and Smithsonian Magazine, emphasize the technical breakthrough in growing hindbrain neurons and its implications for treating ALS and SMA. However, perspectives vary on the certainty of the findings. While Stanford and Nature present the dual-origin model as a definitive discovery, Smithsonian Magazine notes dissent from experts like Alex Pollen of UC San Francisco and Cecilia Moens of the Fred Hutchinson Cancer Center. These critics argue that the two cell populations might originate from a single, short-lived progenitor or that cell fates can swap temporarily, challenging the idea that the developmental paths are permanently locked. Despite these scientific debates, the consensus among major outlets is that the ability to grow hindbrain neurons in a lab represents a significant step forward for neurodegenerative disease research.

Why it matters

The inability to grow hindbrain neurons in laboratories has hindered research into fatal diseases like ALS and SMA for decades. By identifying the correct progenitor cells, researchers can now model these diseases in vitro, potentially accelerating the development of regenerative therapies. Additionally, understanding the hindbrain's role in hunger regulation may offer insights into the mechanisms of weight-loss drugs like semaglutide.

What to watch

Researchers plan to extend their studies to determine the developmental origins of the spinal cord and to investigate exactly how SMA and ALS compromise hindbrain neuron function. The team aims to use these new lab-grown models to develop regenerative therapies for these devastating conditions.